Oportuzumab monatox

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 11:26, 31 July 2009 (No ATC code). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Oportuzumab monatox
Monoclonal antibody
Type?
SourceHumanized
TargetCD326
Clinical data
ATC code
  • none
Identifiers
CAS Number
Chemical and physical data
FormulaC3072H4723N877O952S12
Molar mass69558.48 g·mol−1

Oportuzumab monatox (proposed INN) is a monoclonal antibody used as an antineoplastic. It binds to CD326.[1]

References

  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Template:Humanizedmonoclonals

Retrieved from "https://en.wikipedia.org/w/index.php?title=Oportuzumab_monatox&oldid=305259742"